Clinical Trial Update: Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating standard care plus cryopreserved human umbilical cord (TTAX01) for non-healing venous leg ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• TTAX01 (cryopreserved human umbilical cord) (human umbilical cord-derived therapy)

Snippet

Sponsor: BioTissue Holdings, Inc | Conditions: Venous Leg Ulcer | Phase 2 | Status: COMPLETED